Samenvatting
Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of immature myeloid cells that accumulate during pathological conditions such as cancer and are associated with a poor clinical outcome. MDSC expansion hampers the host anti-tumor immune response by inhibition of T cell proliferation, cytokine secretion, and recruitment of regulatory T cells. In addition, MDSC exert non-immunological functions including the promotion of angiogenesis, tumor invasion, and metastasis. Recent years, MDSC are considered as a potential target in solid tumors and hematological malignancies to enhance the effects of currently used immune modulating agents. This review focuses on the characteristics, distribution, functions, cell-cell interactions, and targeting of MDSC in hematological malignancies including multiple myeloma, lymphoma, and leukemia.
| Originele taal-2 | English |
|---|---|
| Artikelnummer | 349 |
| Pagina's (van-tot) | 1-11 |
| Aantal pagina's | 11 |
| Tijdschrift | Frontiers in Oncology |
| Volume | 4 |
| Vroegere onlinedatum | 8 dec. 2014 |
| DOI's | |
| Status | Published - 8 dec. 2014 |
Vingerafdruk
Duik in de onderzoeksthema's van 'Myeloid-derived suppressor cells as therapeutic target in hematological malignancies.'. Samen vormen ze een unieke vingerafdruk.Citeer dit
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver